Spearman rank correlation coefficients and 95% Cl for the absolute numbers of MDCs and PDC (mL blood) versus absolute CD4 or CD8 counts (cells/mm3)
. | P (95% Cl) . |
|---|---|
| CD4 correlations | |
| KS group | |
| CD4 vs MDC | .92 (.71-.98)* |
| CD4 vs PDC | .56 (-.05-.87) |
| Non-KS group | |
| CD4 vs MDC | .94 (.56-.99)* |
| CD4 vs PDC | .94 (.56-1.00)* |
| CD8 correlations | |
| KS group | |
| CD8 vs MDC | .573 (-.04-.87) |
| CD8 vs PDC | .509 (-.13-.85) |
| Non-KS group | |
| CD8 vs MDC | .829 (.0519-.98)* |
| CD8 vs PDC | .829 (.0519-.98)* |
. | P (95% Cl) . |
|---|---|
| CD4 correlations | |
| KS group | |
| CD4 vs MDC | .92 (.71-.98)* |
| CD4 vs PDC | .56 (-.05-.87) |
| Non-KS group | |
| CD4 vs MDC | .94 (.56-.99)* |
| CD4 vs PDC | .94 (.56-1.00)* |
| CD8 correlations | |
| KS group | |
| CD8 vs MDC | .573 (-.04-.87) |
| CD8 vs PDC | .509 (-.13-.85) |
| Non-KS group | |
| CD8 vs MDC | .829 (.0519-.98)* |
| CD8 vs PDC | .829 (.0519-.98)* |
Correlations were assessed separately for each of the matched KS patients and controls. For one KS patient, PDC and MDC numbers were unavailable.
Significant at P < .05.